Mineralys Looks To Path Ahead For MLS-101 In Hypertension

 
• By Alaric DeArment
  
Mineralys announced positive topline data from its Phase II study of MLS-101 in hypertension • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business